Reuters UK Business

By Twesha Dikshit and Ragini Mathur (Reuters) -European shares closed flat on Wednesday, surrendering early session gains, as healthcare stocks felt the pinch from U.S. President Donald Trump’s latest threat to impose higher tariffs on pharmaceutical imports. The pan-European STOXX 600 index closed 0.06% lower, breaking its two-day winning streak despite starting the session on …

European shares end flat as healthcare stocks weigh after Trump’s tariff threat Read More »

(Reuters) -British equities closed marginally higher on Wednesday, as investors assessed a slew of corporate earnings and awaited a Bank of England rate cut on Thursday. The blue-chip FTSE 100 was up 0.2%, rising for a third consecutive session after touching a four-month low on Friday. The domestically focused midcap FTSE 250 rose 0.1%. Energy …

UK stocks rise as investors assess corporate results ahead of BoE rate decision Read More »

(Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported on Wednesday, citing people familiar with the matter. Shares of Avidity rose 23% to $47.1. It has a market value of $4.6 billion, according to LSEG data. Novartis has been evaluating a bid for Avidity and …

Novartis weighs deal for biotech Avidity Biosciences, FT reports Read More »

MADRID (Reuters) -Spain is no longer considering the option of buying U.S.-made F-35 fighter jets and is choosing between European-made Eurofighter and the so-called Future Combat Air System (FCAS), a defence ministry spokesperson said on Wednesday. The spokesperson was confirming an earlier report by El Pais newspaper that the government had shelved plans to buy …

Spain rules out buying F-35, choosing between Eurofighter or FCAS Read More »

By Gwladys Fouche OSLO (Reuters) -The ethics watchdog for Norway’s $1.9 trillion sovereign wealth fund, the world’s largest, said on Wednesday it should have considered whether a company that services Israel’s fighter jets ought to be assessed for possible divestment. The influential fund’s holdings in Israel – nearly $2 billion of shares in 65 companies …

Norway fund’s ethics watchdog acknowledges shortcoming in scrutiny of Israeli investment Read More »

By Charlie Conchie and Pratima Desai LONDON (Reuters) -Glencore will keep its primary listing in London, rejecting a move to the United States for now in a rare win for the city’s markets, which have been shrinking due to a dearth of new share issues. The London-listed miner said on Wednesday that a move across …

Glencore rejects US listing in boost for UK markets Read More »

MADRID (Reuters) -Sabadell shareholders on Wednesday unanimously approved the sale of its TSB business in Britain to Santander, which analysts see as a defensive move against BBVA’s hostile takeover bid. The shareholders also backed a one-off cash dividend worth 2.5 billion euros ($2.90 billion) from the TSB sale. Sabadell agreed last month to sell TSB …

Sabadell shareholders approve TSB sale, $2.9 billion special dividend Read More »